These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 12009281

  • 1. Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS).
    Furrie E, Smith RE, Turner MW, Strobel S, Mowat AM.
    Vaccine; 2002 May 22; 20(17-18):2254-62. PubMed ID: 12009281
    [Abstract] [Full Text] [Related]

  • 2. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen.
    Mowat AM, Donachie AM, Jägewall S, Schön K, Löwenadler B, Dalsgaard K, Kaastrup P, Lycke N.
    J Immunol; 2001 Sep 15; 167(6):3398-405. PubMed ID: 11544331
    [Abstract] [Full Text] [Related]

  • 3. The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.
    Robson NC, Beacock-Sharp H, Donachie AM, Mowat AM.
    Immunology; 2003 Sep 15; 110(1):95-104. PubMed ID: 12941146
    [Abstract] [Full Text] [Related]

  • 4. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens.
    Mowat AM, Maloy KJ, Donachie AM.
    Immunology; 1993 Dec 15; 80(4):527-34. PubMed ID: 7508416
    [Abstract] [Full Text] [Related]

  • 5. Oral vaccination with immune stimulating complexes.
    Mowat AM, Smith RE, Donachie AM, Furrie E, Grdic D, Lycke N.
    Immunol Lett; 1999 Jan 15; 65(1-2):133-40. PubMed ID: 10065639
    [Abstract] [Full Text] [Related]

  • 6. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses.
    Smith RE, Donachie AM, Grdic D, Lycke N, Mowat AM.
    J Immunol; 1999 May 01; 162(9):5536-46. PubMed ID: 10228035
    [Abstract] [Full Text] [Related]

  • 7. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ, Donachie AM, O'Hagan DT, Mowat AM.
    Immunology; 1994 Apr 01; 81(4):661-7. PubMed ID: 7518802
    [Abstract] [Full Text] [Related]

  • 8. Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS.
    Estrada A, Laarveld B, Li B, Redmond MJ.
    Immunol Invest; 1995 Aug 01; 24(5):819-28. PubMed ID: 8543345
    [Abstract] [Full Text] [Related]

  • 9. Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.
    Smith RE, Donachie AM, McLaren FH, Mowat AM.
    Immunology; 1998 Apr 01; 93(4):556-62. PubMed ID: 9659229
    [Abstract] [Full Text] [Related]

  • 10. Immune stimulating complexes as mucosal vaccines.
    Smith RE, Donachie AM, Mowat AM.
    Immunol Cell Biol; 1998 Jun 01; 76(3):263-9. PubMed ID: 9682970
    [Abstract] [Full Text] [Related]

  • 11. The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action.
    Grdic D, Smith R, Donachie A, Kjerrulf M, Hörnquist E, Mowat A, Lycke N.
    Eur J Immunol; 1999 Jun 01; 29(6):1774-84. PubMed ID: 10382739
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC, Donachie AM, Mowat AM.
    Eur J Immunol; 2008 May 01; 38(5):1238-46. PubMed ID: 18398931
    [Abstract] [Full Text] [Related]

  • 13. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.
    Mowat AM, Donachie AM, Reid G, Jarrett O.
    Immunology; 1991 Mar 01; 72(3):317-22. PubMed ID: 2026440
    [Abstract] [Full Text] [Related]

  • 14. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
    Kunisawa J, Takahashi I, Okudaira A, Hiroi T, Katayama K, Ariyama T, Tsutsumi Y, Nakagawa S, Kiyono H, Mayumi T.
    Eur J Immunol; 2002 Aug 01; 32(8):2347-55. PubMed ID: 12209648
    [Abstract] [Full Text] [Related]

  • 15. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.
    Maloy KJ, Donachie AM, Mowat AM.
    Eur J Immunol; 1995 Oct 01; 25(10):2835-41. PubMed ID: 7589080
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
    Robson NC, Beacock-Sharp H, Donachie AM, Mowat AM.
    Immunology; 2003 Jul 01; 109(3):374-83. PubMed ID: 12807483
    [Abstract] [Full Text] [Related]

  • 17. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM.
    Lycke N.
    Cell Microbiol; 2004 Jan 01; 6(1):23-32. PubMed ID: 14678328
    [Abstract] [Full Text] [Related]

  • 18. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.
    Spahn TW, Weiner HL, Rennert PD, Lügering N, Fontana A, Domschke W, Kucharzik T.
    Eur J Immunol; 2002 Apr 01; 32(4):1109-13. PubMed ID: 11920578
    [Abstract] [Full Text] [Related]

  • 19. Peyer's patches are required for oral tolerance to proteins.
    Fujihashi K, Dohi T, Rennert PD, Yamamoto M, Koga T, Kiyono H, McGhee JR.
    Proc Natl Acad Sci U S A; 2001 Mar 13; 98(6):3310-5. PubMed ID: 11248075
    [Abstract] [Full Text] [Related]

  • 20. Oral tolerance and accessory-cell function of Peyer's patches.
    Tomasi TB, Barr WG, Challacombe SJ, Curran G.
    Ann N Y Acad Sci; 1983 Jun 30; 409():145-63. PubMed ID: 6191610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.